AI & Machine Learning

The powertrain giant crushed market expectations with a 29% revenue surge in 2025, fueled by heavy-duty engines, while eyeing a global and green future.

Scotiabank reports a strong start to 2026, with adjusted earnings beating forecasts as international divestitures and domestic growth signal a new focus.

Planet Fitness reports a 12.1% revenue surge and adds 1.1 million members, proving its model's resilience even as Wall Street weighs future growth.

After a massive divestiture, Brightstar Lottery slashes debt, rewards investors, and sets its sights on digital expansion in Italy and Brazil.

SLC Digital and Tracer Labs partner to combat rampant account takeover fraud, combining hardware-rooted security with a privacy-first digital identity.

A new platform, Venn.ai, promises to let AI take real action in business apps, but with a critical feature: a human-in-the-loop safety switch.

After an 8-year hiatus, Elizabeth Arden launches Eternal Aura. A look at the strategy combining a new star, wellness science, and heritage to reclaim its spot.

Riding a wave of 41% Q4 revenue growth and nearing profitability, the diagnostics firm will showcase its lung cancer solutions at two major conferences.

A new partnership brings premium anime to Times Prime members, a strategic move to capture India's booming, multi-billion dollar anime market.

With $1.2M in new funding, Validfor is unleashing agentic AI to tackle pharma's billion-dollar compliance problem and slash validation times.

Nokia and AWS launch a thinking 5G network with du and Orange. Their agentic AI promises to unlock the true business potential of network slicing.

A new 'technology-only' law firm has been approved in the UK. Can its deterministic AI make legal help more affordable and consistent for everyone?

After a challenging year, iGaming affiliate Gentoo Media posts record Q4 profits, signaling a successful pivot to a leaner model ahead of a key refinancing.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

Avacta's pre|CISION therapy shows faster, more potent, and more selective tumor targeting than Enhertu in an AI-driven study, paving the way for 2026 trials.

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?

With key conferences ahead, Supernus Pharmaceuticals must prove its strategy can deliver growth in the competitive central nervous system drug landscape.

Creatd Inc. executes a 1:20 reverse stock split to chase a national exchange listing. Is it a strategic masterstroke or a sign of deeper struggles?

Fintech unicorn Clear Street pulls its much-anticipated IPO, a move that highlights a tough market forcing many tech firms to reconsider public debuts.

A new partnership brings an FDA-designated breakthrough device to more patients, fueled by a key Medicare payment that could reshape the trauma market.